Patient and provider costs of the new BPaL regimen for drugresistant tuberculosis treatment in South Africa A costeffectiveness analysis

Denise EvansKamban HirasenClive RamushuLawrence LongE SinanovicFrancesca CONRADIEPauline HowellX PadanilamH FerreiraEbrahim VariavaShakira RajaramE et al2025-04-12WOS1932-6203https://hdl.handle.net/10539/44732Patient and provider costs of the new BPaL regimen for drugresistant tuberculosis treatment in South Africa A costeffectiveness analysisJournal Article